Device Trial Radar · NCT04024748
Verification of Imaging System PCD-1000A
Last checked: Nov 19, 2026Latest source record: Aug 6, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Oct 22, 2019
Primary completion
Nov 26, 2019
Study completion Nov 26, 2019
Sponsor
- Lead sponsor
- Canon Medical Systems, USANot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 18, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain. * Define and confirm all supported clinical protocols * Evaluate performance
Conditions
- Cancer Patients
Interventions
PET/CT imagingDevice
Subjects will be have a PET/CT scan with PCD-1000A following their scheduled routine PET/CT scan. There will be no additional administration of radiopharmaceutical for the study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confirm that PCD-1000A PET/CT System is Effective for Its Intended UseTime frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Steinberg Diagnostic Medical Imaging Centers
Henderson, Nevada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.